Results for 'AA'
The Role of MSLs in Achieving Health Equity
health equity, healthcare inequity, pharmaceutical companies, patient advocacy, FDA regulations
In this episode, Ariel Katz, co-founder of H1, joins Tom Caravela to discuss the crucial topic of health equity. Ariel shares insights into his background and the mission of H1, defining health equity and exploring the causes of healthcare inequity. The conversation delves into the roles of MSL…
Jul 12th • 29 mins listen
The Art of Story Telling for Impactul Engagement
storytelling in medical affairs, engaging Key Opinion Leaders, effective storytelling techniques, building relationships with KOLs, impactful communication in MSLs
In this episode, Angela Valadez joins Tom Caravela to explore the power of storytelling in medical affairs. Angela shares her journey and emphasizes the critical role storytelling plays in engaging Key Opinion Leaders (KOLs). She discusses the benefits and key elements of effective storyte…
Oct 11th • 30 mins listen
New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
Drs. Shaalan Beg and Travis Osterman discuss a machine learning model, recently featured in JCO Clinical Cancer Informatics, that uses electronic health record data to accurately predict the effectiveness and toxicity of treatment with immune checkpoint inhibitors. The new AI model can be use…
Mar 21st • 16 mins listen
Recent Advances and Future Directions in Oncology
Listen on Everand Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in acute myeloid leukemia, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung c…
Nov 23rd • 364 mins listen
Industry Challenges Contribute to Financial Toxicity
In this third panel discussion from ONS’s Health Policy Summit in Washington DC, Alan Balch, PhD, Patient Advocate Foundation chief executive officer, Mike Ybarra, MD, FAAEM, FACEP, vice president of medical affairs for the Pharmaceutical Research Manufacturers Association, and Jeannine…
Feb 18th • 66 mins listen
CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation
“Just like with anything we do in oncology, a lot of education is required. Nurses and coordinators are critical to start the education and provide effective resources that are reinforced throughout the treatment,” ONS member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, F…
May 24th • 40 mins listen